| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5727364 | Journal of Vascular and Interventional Radiology | 2017 | 9 Pages |
Abstract
Treatment with the GORE EXCLUDER is effective with acceptable reintervention rates in the long-term and few device-related adverse events or ruptures up to 10 years. Observed late adverse events and new-onset endoleaks emphasize the need for long-term surveillance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Claire G. BSc, Suzanne MSc, PhD, Steven M.M. MD, Ignace F.J. MD, PhD, Clark J. MD, PhD, Michel M.P.J. MD, PhD,